Clinical trials
Active, not recruiting Phase 4 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| University of Oxford | 2 |
| Anders Fink-Jensen, MD, DMSci | 1 |
| Campus Bio-Medico University | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| MaryAnn Banerji | 1 |
| Mayo Clinic | 1 |
| National Center for Global Health and Medicine, Japan | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
| Universidad de Colima | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 16 |
| Diabetes Mellitus | 3 |
| Obesity | 3 |
| Overweight | 2 |
| Angina Pectoris | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Genetic Diseases, Inborn | 1 |
| Heart Failure | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.